Our Bureau
Washington
An eminent Indian-American radiation oncologist applauded India’s budget announcement for vaccination of girls, who are between the age of 9 and 14, against cervical cancer.
“The budget’s emphasis on preventive programs for cervical cancer is a commendable step towards addressing a critical public health issue in India. The initiative to vaccinate girls aged 9-14 against cervical cancer is particularly praiseworthy, as this disease claims the lives of over 150 women daily in the country,” Dr Dattatreyudu Nori said.
A recipient of Padma Shri in 2015 for his contributions in the field of medicine, Dr Nori said cervical cancer ranks as the second most common cancer among women in India, with more than 85,000 new cases diagnosed annually and approximately 50,000 deaths reported each year.
The incidence of cancer cases is projected to increase se from 1.46 million in 2022 to 1.57 million in 2025. This increase is attributed to advancements in cancer diagnostics, improved data capture, and ongoing epidemiological transitions.
“Furthermore, cancer patterns in India highlight the need for strategic, well-planned preventive measures, including health education, cancer awareness, screening, early detection, and risk reduction programs, to mitigate the growing cancer burden, he said in response to a question.
Dr. Dattatreyudu Nori is a noted Indo-American radiation oncologist and was once named one of the top doctors in America for the treatment of cancers in women by the women’s magazine Ladies’ Home Journal. Dr Nori is an internationally acclaimed oncologist with significant leadership roles in prestigious institutions such as the Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital at Cornell University, he has dedicated his career to advancing the field of oncology.
